跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
可多华 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Doxazosin Mesylate Extended Release Tablets
Approved
化学药品
Doxazosin Mesylate Extended Release Tablets
Viatris Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jul 4, 2023
Approval ID
8TELo238Mfn
Company
Viatris Pharma GmbH
Type
化学药品
Approval Details
Approval Id
8TELo238Mfn
Approval Number
国药准字HJ20170174
Generic Name
甲磺酸多沙唑嗪缓释片
Generic Name En
Doxazosin Mesylate Extended Release Tablets
Trade Name
可多华
Drug Type
化学药品
Dosage Form
片剂
Strength
4mg
Reg Date
2023-07-04
Expired Date
2028-07-03
Company Name
Viatris Pharma GmbH
Production Company Name
Viatris Pharmaceuticals LLC
Company Detail Path
/organization/viatris-pharma-gmbh
Production Company Detail Path
/organization/viatris-pharmaceuticals-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 4, 2023
Approval ID
8TELo238Mfn
Type
化学药品
Back to NMPA Approvals
